CyMedica Orthopedics said it has launched a clinical trial to evaluate the effectiveness of its E-vive muscle-strengthening device and patient engagement system in knee osteoarthritis patients. Researchers will combine the data generated by the E-vive neuromuscular electrical stimulation device with the activity and health data collected by commercially available wearable smartwatch devices to determine the effect […]
Neuromodulation/Neurostimulation
Saluda Medical touts Evoke closed-loop SCS studies
Saluda Medical today released data from two studies of its Evoke ECAP-controlled closed-loop spinal cord stimulator. The Evoke SCS system is designed to measure the spinal cord’s response to stimulation and adjust on every pulse to maintain activation within the patient’s therapeutic window, the Australian company said. Results from both the Evoke and Avalon studies […]
Checkpoint Surgical touts nerve monitor study results
Checkpoint Surgical today announced the results of a study that called its handheld nerve monitor a safe and reliable alternative to existing technology for neural monitoring during surgery. The retrospective study compared the use of the Cleveland, Ohio-based company’s Checkpoint nerve stimulator/locator to Medtronic’s nerve integrity monitor for vagal, recurrent and superior laryngeal nerve monitoring […]
Abbott inks neuroscience research deal with NIH
Abbott (NYSE:ABT) said today that it inked a partnership deal with the National Institutes of Health to support the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN initiative. The NIH’s BRAIN initiative aims to accelerate neuroscience research and advancements, Chicago-area based Abbott said. Through the partnership, Abbott will provide its neuromodulation tech, including directional deep brain […]
Omron joins $35m Theranica Series B
Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review. Funding in the round, which was initially announced in March, was led by […]
HRS 2019: Parasym ear stim device shows promise in AFib
Noninvasive neurostimulation of the ear shows promise when it comes to treating atrial fibrillation, according to clinical study results presented today at the Heart Rhythm Society’s annual scientific sessions, held in San Francisco. University of Oklahoma researchers over a six-month period studied the effects of London-based Parasym‘s noninvasive neurostimulation device on roughly 50 paroxysmal AFib […]
Boston Scientific gets into spine with $465 Vertiflex buy
Boston Scientific (NYSE:BSX) moved into the orthopedics space with a $465 million buyout of spinal implant maker Vertiflex. The deal, announced this morning and expected to close late in the second quarter of 2019, includes commercial milestones spaced out over three years. Carlsbad, Calif.-based Vertiflex makes the Superion decompression device for treating lumbar spinal stenosis, which […]
Medtronic touts EvolveSM SCS workflow study data
Medtronic (NYSE:MDT) today released three-month results from a post-market clinical study of spinal cord stimulation provided through its EvolveSM workflow, touting effective pain relief and improved function in patients with chronic intractable back and leg pain. Data from the trial was presented at the American Society of Interventional Pain Physicians’ annual meeting, the Fridley, Minn.-based company said. […]
NeuroSigma wins FDA nod for ADHD device
UPDATED April 24, 2019, with comment from NeuroSigma. NeuroSigma won de novo clearance from the FDA last week to put the first medical device for treating attention-deficit hyperactivity disorder on the U.S. market. Los Angeles-based NeuroSigma makes the Monarch eTNS system, which is designed to deliver mild electrical signals through a forehead patch to stimulate […]
Brainsway prices downsized $28m IPO
Brainsway yesterday priced its initial public offering in the U.S. slightly below the terms it set earlier this month. The Jerusalem-based company, which is already publicly traded in Israel, said April 3 that it planned to float 2.5 million American Depository shares at roughly $11.94 apiece. Each ADS is would represent two ordinary shares, slated […]
Helius Medical shares tank on FDA denial
Shares in Helius Medical Technologies (NSDQ:HSDT) tanked yesterday after the company said the FDA shot down its clearance bid for the portable neuromodulation device it developed. The Newtown, Pa.-based company’s PONS system is designed to treat neurological symptoms through electrical stimulation of nerves in the tongue. A trial of the PONS device in treating patients with […]